Dr. Markus Fido
Chief Executive Officer
VelaLabs GmbH
Markus has more than 20 years of experience in pharmaceutical industry, with focus in vaccines, recombinant proteins and immune therapeutics. He has profound expertise in regulatory aspects such as third party audits, authority inspections and GMP guidelines. He has a management consulting education and holds a doctorate degree in immunology/biochemistry from the Technical University of Graz, Austria. Markus started his carrier at a Novartis “Spin off” in Vienna in 2006, he has acquired the oncology division and founded Velalabs & Meridian Biopharmaceutics. Besides serving as a CEO and formal Managing Director, Markus has also taken responsibilities as a Head of Regulatory Affairs within the Quality Operations team. Markus was previously Head Quality Control at Igeneon/Aphton Biopharma where he was responsible for all QC aspects of pre-clinical and clinical projects such as stability studies, specifications, method validation, and product release. Before that he was Group Leader of Immunology and Product Development at Biomin GmbH, Head Biochemical Control at Baxter AG and Head Quality Operations at Octapharma AG. • 2 years Biomin AG Cell culture lab, development of immune enhancer drugs • 6 years Baxter Inc Quality control of vaccines & coagulation factors • 2 years Octapharma Head of Quality Operations & Quality Control (plasma products) • 3 years Novartis AG Oncology, Cancer immune therapy, Quality + RA • 15 years Management Buy-out (founder and CEO of 2 Biotech companies) VelaLabs & Meridian Biopharmaceuticals Products: Biologics, Biopharmaceuticals, Biosimilars, ATMPs, Monoclonals, Antibodies Focus: Analytics, Quality Control, Process & Clinical Development, Regulatory Affairs
Root Cause Analysis for Oil and Gas Industry
4. - 6. April 2022
Online Live Stream
HAZID and HAZOP Masterclass
14. - 18. February 2022
Online Live Stream
Managing The Abandonment Costs For Oil And Gas Wells
26. - 28. October 2021
Online Live Stream
NEBOSH Certificate in Oil and Gas Operational Safety Maputo
15. - 20. November 2021
Maputo, Mozambique
Fundamanetals of Oil and Gas E&P
21. - 25. March 2022
Online Live Stream
OSH Occupational Safety and Health Masterclass
22. - 26. November 2021
Online Live Stream
Agility in Compliance - Yes, Please!
CONTRIBUTOR View trainer bio View trainer bio View trainer bio View trainer bio View trainer bio...
Imploded Storage Tank
CONTRIBUTOR What Happened? After cleaning with steam a tank was quenched with cold water to shorten...
Importance of a mobile banking app within a bank’s multi-channel strategy
CONTRIBUTOR View trainer bio View trainer bio View trainer bio View trainer bio View trainer bio...
Digital Banking: The Operational Backbone
CONTRIBUTOR View trainer bio View trainer bio View trainer bio View trainer bio View trainer bio...
Queens of safety inventions
Throughout history, women were underestimated and it was unbelievable for society if a woman came up with...
EHS Opportunities due to COVID-19 – seizing the “new normal”
CONTRIBUTOR On March 11, 2020, the World Health Organization officially declared the novel coronavirus a pandemic....
Neil Murphy
Business Manager
TriOptima, OSTTRA, UK
Amadeus von Kummer
Vice President BU Banking & Finance
FinTecSystems, Germany
Vitold Sanotskyy
Founder & CEO of Internal Startup “Nicole”
Raiffeisen Bank International, Austria
Jurgen Vandenbroucke
Managing Director
everyoneINVESTED (KBC group), Belgium
Aki Stamatis
Director
Fourfront Group, UK
Ottavia Pelloni
Worksphere Strategist
Il Prisma
Dr. Markus Fido
Chief Executive Officer
VelaLabs GmbH
Markus has more than 20 years of experience in pharmaceutical industry, with focus in vaccines, recombinant proteins and immune therapeutics. He has profound expertise in regulatory aspects such as third party audits, authority inspections and GMP guidelines. He has a management consulting education and holds a doctorate degree in immunology/biochemistry from the Technical University of Graz, Austria. Markus started his carrier at a Novartis “Spin off” in Vienna in 2006, he has acquired the oncology division and founded Velalabs & Meridian Biopharmaceutics. Besides serving as a CEO and formal Managing Director, Markus has also taken responsibilities as a Head of Regulatory Affairs within the Quality Operations team. Markus was previously Head Quality Control at Igeneon/Aphton Biopharma where he was responsible for all QC aspects of pre-clinical and clinical projects such as stability studies, specifications, method validation, and product release. Before that he was Group Leader of Immunology and Product Development at Biomin GmbH, Head Biochemical Control at Baxter AG and Head Quality Operations at Octapharma AG. • 2 years Biomin AG Cell culture lab, development of immune enhancer drugs • 6 years Baxter Inc Quality control of vaccines & coagulation factors • 2 years Octapharma Head of Quality Operations & Quality Control (plasma products) • 3 years Novartis AG Oncology, Cancer immune therapy, Quality + RA • 15 years Management Buy-out (founder and CEO of 2 Biotech companies) VelaLabs & Meridian Biopharmaceuticals Products: Biologics, Biopharmaceuticals, Biosimilars, ATMPs, Monoclonals, Antibodies Focus: Analytics, Quality Control, Process & Clinical Development, Regulatory Affairs
Dr. Markus Fido
Description
Root Cause Analysis for Oil and Gas Industry
4. - 6. April 2022
Online Live Stream
HAZID and HAZOP Masterclass
14. - 18. February 2022
Online Live Stream
Managing The Abandonment Costs For Oil And Gas Wells
26. - 28. October 2021
Online Live Stream
NEBOSH Certificate in Oil and Gas Operational Safety Maputo
15. - 20. November 2021
Maputo, Mozambique
Fundamanetals of Oil and Gas E&P
21. - 25. March 2022
Online Live Stream
OSH Occupational Safety and Health Masterclass
22. - 26. November 2021
Online Live Stream
Agility in Compliance - Yes, Please!
CONTRIBUTOR View trainer bio View trainer bio View trainer bio View trainer bio View trainer bio...
Imploded Storage Tank
CONTRIBUTOR What Happened? After cleaning with steam a tank was quenched with cold water to shorten...
Importance of a mobile banking app within a bank’s multi-channel strategy
CONTRIBUTOR View trainer bio View trainer bio View trainer bio View trainer bio View trainer bio...
Digital Banking: The Operational Backbone
CONTRIBUTOR View trainer bio View trainer bio View trainer bio View trainer bio View trainer bio...
Queens of safety inventions
Throughout history, women were underestimated and it was unbelievable for society if a woman came up with...
EHS Opportunities due to COVID-19 – seizing the “new normal”
CONTRIBUTOR On March 11, 2020, the World Health Organization officially declared the novel coronavirus a pandemic....
Neil Murphy
Business Manager
TriOptima, OSTTRA, UK
Amadeus von Kummer
Vice President BU Banking & Finance
FinTecSystems, Germany
Vitold Sanotskyy
Founder & CEO of Internal Startup “Nicole”
Raiffeisen Bank International, Austria
Jurgen Vandenbroucke
Managing Director
everyoneINVESTED (KBC group), Belgium
Aki Stamatis
Director
Fourfront Group, UK
Ottavia Pelloni
Worksphere Strategist
Il Prisma